Washington, Sep 17 (AP) An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.

The vote Friday, 61-3, was a blow to the Biden administration's effort to shore up people's protection against the virus amid the highly contagious delta variant.

Also Read | COVID-19 Rebounds, Affects Children in China As Vaccines Turn Ineffective.

Over several hours of discussion, members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses.

And they complained that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the US experience. (AP)

Also Read | China Says It Agrees with EAM S Jaishankar; Says Sino-India Ties Have Their Own ‘Intrinsic Logic’.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)